SCHEMBL724084

SCHEMBL724084

O=C(Nc1ccc(Oc2ccnc3cc(-c4ccccc4)oc23)c(F)c1)c1c(I)ccn(-c2ccc(F)cc2)c1=O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 17/20 0.67
AXL P30530 9/20 0.65
TYRO3 Q06418 5/20 0.53
MST1R Q04912 4/20 0.53
MERTK Q12866 4/20 0.52
FLT3 P36888 3/20 0.52
LCK P06239 2/20 0.52
KIT P10721 2/20 0.52
KDR P35968 2/20 0.52
PLK4 O00444 1/20 0.52
ABL1 P00519 1/20 0.52
NTRK1 P04629 1/20 0.52
RET P07949 1/20 0.52
PDGFRA P16234 1/20 0.52
PRKACA P17612 1/20 0.52
ABL2 P42684 1/20 0.52
FRK P42685 1/20 0.52
DDR1 Q08345 1/20 0.52
PDE4D Q08499 1/20 0.52
MAP4K2 Q12851 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL721795 0.91 MET (0.55) METAXLTYRO3MST1RMERTK
SCHEMBL723382 0.90 MET (0.58) METAXLTYRO3MST1RMERTK
SCHEMBL723448 0.90 MET (0.69) METAXLTYRO3MST1RMERTK
SCHEMBL722103 0.88 MET (0.65) METAXLTYRO3MST1RMERTK
SCHEMBL16817179 0.85 MET (0.51) METAXLTYRO3MERTKFLT3
SCHEMBL16817164 0.82 MET (0.48) METAXLTYRO3MST1RMERTK
SCHEMBL16817165 0.81 MET (0.54) METAXLTYRO3MST1RMERTK
SCHEMBL721614 0.81 AXL (0.60) METAXLTYRO3MST1RMERTK
SCHEMBL22234273 0.79 MET (0.81) METAXLTYRO3MST1RMERTK
SCHEMBL16870533 0.79 AXL (1.00) METAXL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609100-B1 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2015-06-24 EP disclosed
EP-2609100-B1 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2015-06-24 EP disclosed
US-9006440-B2 Furopyridine derivatives MERCK PATENT GMBH (DE) 2015-04-14 US disclosed
US-9006440-B2 Furopyridine derivatives MERCK PATENT GMBH (DE) 2015-04-14 US disclosed
US-9006440-B2 Furopyridine derivatives MERCK PATENT GMBH (DE) 2015-04-14 US disclosed
US-20130225569-A1 FUROPYRIDINE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2013-08-29 US disclosed
US-20130225569-A1 FUROPYRIDINE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2013-08-29 US disclosed
WO-2012025187-A2 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2012-03-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130225569-A1 FUROPYRIDINE DERIVATIVES SYK, FCGRT, SSB MET 1482/4885AXL 390/4885TYRO3 17/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.